Form4insider filings, from the source

SEC Form 4 · accession 0001144204-16-084074

Aclaris Therapeutics, Inc. · ACRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Feb 22, 2016
Accepted (ET)
Feb 24, 2016 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 22, 2016P11,318$15.9885A2,599,311ISee Footnote
Common StockF2,F1Feb 23, 2016P28,408$17.6187A2,627,719ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses